Heart conditions

Every manufacturer places this the same way.

scroll for all 13 products →

Which section of each manufacturer's label carries this concept
Section	Zydus Pharmaceuticals UK Ltd1mg Oral Solution	Viatris (formerly Mylan or Upjohn)10mg Tablets	Ipca Laboratories UK Ltd10mg Tablets	Dr. Reddy's Laboratories (UK) Ltd10mg Tablets	Flamingo Pharma (UK) Ltd10mg Tablets	Sandoz Limited10mg Tablets	Amarox Limited10mg Tablet	Aurobindo Pharma - Milpharm Ltd.10mg Tablets	Rosemont Pharmaceuticals Limited1mg Oral Solution	Amarox Limited5mg Tablets	Sandoz Limited5mg Tablets	Zentiva2.5mg Tablets	Viatris (formerly Mylan or Upjohn)10mg Tablets
ContraindicatedThe label says it must not be used.	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated
WarningThe label says it can be used, with care.
InteractionThe label says another medicine affects it.
PregnancyThe label gives advice for pregnancy or breastfeeding.
ExcipientThe label lists it as an ingredient, not a restriction.

Contraindicated
- Ipca Laboratories UK Ltd
  10mg Tablets · revised 15/05/2025
  191–227 of 402 characters
  Source SmPC ↗
- Amarox Limited
  10mg Tablet · revised 06/11/2024
  192–228 of 402 characters
  Source SmPC ↗
- Amarox Limited
  5mg Tablets · revised 06/11/2024
  182–218 of 385 characters
  Source SmPC ↗
- Zentiva
  2.5mg Tablets · revised 18/12/2023
  191–227 of 401 characters
  Source SmPC ↗
- Viatris (formerly Mylan or Upjohn)
  10mg Tablets · revision unknown
  191–227 of 402 characters
  Source SmPC ↗
Amlodipine is contraindicated in patients with: • hypersensitivity to dihydropyridine derivatives, Amlodipine or to any of the excipients listed in section 6.1. • severe hypotension. • shock (including cardiogenic shock). • obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis). • haemodynamically unstable heart failure after acute myocardial infarction.
Identical in all 5 labels. Surrounding text shown from Ipca Laboratories UK Ltd.
Contraindicated
- Viatris (formerly Mylan or Upjohn)
  10mg Tablets · revision unknown
  200–235 of 406 characters
  Source SmPC ↗
- Sandoz Limited
  10mg Tablets · revised 20/09/2022
  191–226 of 395 characters
  Source SmPC ↗
- Aurobindo Pharma - Milpharm Ltd.
  10mg Tablets · revised 13/04/2026
  184–219 of 388 characters
  Source SmPC ↗
- Sandoz Limited
  5mg Tablets · revised 20/09/2022
  191–226 of 395 characters
  Source SmPC ↗
Amlodipine is contraindicated in patients with: • hypersensitivity to the active substance, dihydropyridine derivatives or to any of the excipients listed in section 6.1 • severe hypotension • shock (including cardiogenic shock) • obstruction of the outflow tract of the left ventricle (e.g. high-grade aortic stenosis) • haemodynamically unstable heart failure after acute myocardial infarction
Identical in all 4 labels. Surrounding text shown from Viatris (formerly Mylan or Upjohn).
Contraindicated
- Zydus Pharmaceuticals UK Ltd
  1mg Oral Solution · revised 13/04/2026
  191–227 of 396 characters
  Source SmPC ↗
- Flamingo Pharma (UK) Ltd
  10mg Tablets · revised 27/08/2025
  182–218 of 385 characters
  Source SmPC ↗
- Rosemont Pharmaceuticals Limited
  1mg Oral Solution · revised 14/12/2022
  194–230 of 405 characters
  Source SmPC ↗
Amlodipine is contraindicated in patients with: • Hypersensitivity to dihydropyridine derivatives, amlodipine or to any of the excipients listed in section 6.1. • Severe hypotension. • Shock (including cardiogenic shock). • Obstruction of the outflow tract of the left ventricle (e.g., high grade aortic stenosis). haemodynamically unstable heart failure after acute myocardial infarction
Identical in all 3 labels. Surrounding text shown from Zydus Pharmaceuticals UK Ltd.
Contraindicated
- Dr. Reddy's Laboratories (UK) Ltd
  10mg Tablets · revision unknown
  189–225 of 398 characters
  Source SmPC ↗
Amlodipine is contra-indicated in patients with: • Hypersensitivity to dihydropyridine derivatives, amlodipine or any of the excipients listed in section 6.1. • Severe hypotension. • Shock (including cardiogenic) shock. • Obstruction of the outflow-tract of the left ventricle (e.g. high grade aortic stenosis). • Haemodynamically unstable heart failure after acute myocardial infarction.